Conditional mutation of Brca 1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

Nature Genetics

Volumn 22, Issue 1, 1999, Pages 37-43

  Xu, Xiaoling ^a   Wagner, Kay Uwe ^b   Larson, Denise ^c   Weaver, Zoë ^a   Li, Cuiling ^a   Ried, Thomas ^a   Hennighausen, Lothar ^b   Wynshaw Boris, Anthony ^c   Deng, Chu Xia ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CHROMOSOME 11; CHROMOSOME REARRANGEMENT; EXON; GENE MUTATION; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ALLELE; ANIMAL; APOPTOSIS; CELL LINE; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENE TRANSLOCATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE STRAIN; MUTATION; PATHOLOGY; UDDER;

BRCA1 PROTEIN;

ALLELES; ANIMALS; APOPTOSIS; BRCA1 PROTEIN; CELL LINE; EPITHELIAL CELLS; FEMALE; GENES, P53; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED STRAINS; MUTATION; TRANSLOCATION, GENETIC;

EID: 0032587877     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/8743     Document Type: Article

References (44)

1. Alberg, A.J. & Helzlsouer, K.J. Epidemiology, prevention, and early detection of breast cancer. Curr Opin. Oncol. 9, 505-511 (1997).
2. Hill, A.D., Doyle, J.M., McDermott, E.W. & O'Higgins, N.J. Hereditary breast cancer. Br. J. Surg. 84, 1334-1339 (1997).
3. Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
4. Casey, G. The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol. 9, 88-93 (1997).
5. Chen, Y. et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56, 3168-3172 (1996).
6. Cui, J.Q., Wang, H., Reddy, E.S. & Rao, V.N. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b. Oncol. Rep. 5, 585-589 (1998).
7. Thakur, S. et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17, 444-452 (1997).
8. Wilson, C.A. et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-δ11b. Oncogene 14, 1-16 (1997).
9. Bennett, L.M. et al. Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. Genomics 29, 576-581 (1995).
10. Muris, D.F. et al. Cloning the RAD51 homologue of Schizosaccharomyces pombe. Nucleic Acids Res 21, 4586-4591 (1993).
11. Shinohara, A., Ogawa, H. & Ogawa, T. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69, 457-470 (1992).
12. Shinohara, A. et al. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nature Genet 4, 239-243 (1993).
13. Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275 (1997).
14. Chen, C.F. et al. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J. Biol. Chem. 271, 32863-32868 (1996).
15. Zhang, H. et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713-1721 (1998).
16. Ouchi, T., Monteiro, A.N., August, A., Aaronson, S.A. & Hanafusa, H. BRCA1 regulates p53-dependent gene expression. Proc. Natl Acad. Sci. USA 95, 2302-2306 (1998).
17. Marquis, S.T. et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature Genet. 11, 17-26 (1995).
18. Lane, T.F. et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712-2722 (1995).
19. Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023 (1996).
20. Liu, C.Y., Flesken-Nikitin, A., Li, S., Zeng, Y. & Lee, W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10, 1835-1843 (1996).
21. Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K. & Koller, B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genet. 12, 191-194 (1996).
22. Shen, S.X. et al. A targeted disruption of the murine Brca1 gene causes γ-radiation hypersensitivity and genetic instability. Oncogene 17, 3115-3124 (1998).
23. Ludwig, T., Chapman, D.L., Papaioannou, V.E. & Efstratiadis, A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11, 1226-1241 (1997).
24. Sauer, B. Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392 (1998).
25. Wagner, K.U. et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323-4330 (1997).
26. Hennighausen, L. & Robinson, G.W. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12, 449-455 (1998).
27. Rotter, V., Wolf, D., Pravtcheva, D. & Ruddle, F.H. Chromosomal assignment of the murine gene encoding the transformation-related protein p53. Mol. Cell. Biol. 4, 383-385 (1984).
28. Schrock, E. et al. The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D. Hum. Genet. 97, 256-259 (1996).
29. Xu, X. et al. Centrosome amplification and a defective G2-M checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-396 (1999).
30. Crook, T., Crossland, S., Crompton, M.R., Osin, P. & Gusterson, B.A. p53 mutations in BRCA1-associated familial breast cancer. Lancet 350, 638-639 (1997).
31. Crook, T. et al. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1-and BRCA2-associated breast tumours. Oncogene 17, 1681-1689 (1998).
32. Morgan, S.E. & Kastan, M.B. p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71, 1-25 (1997).
33. Donehower, LA. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
34. Prolla, T.A. DNA mismatch repair and cancer. Curr. Opin. Cell Biol. 10, 311-316 (1998).
35. Kinzler, K.W. & Vogelstein, B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761-763 (1997).
36. Cressman, V.L. et al. Mammary tumor formation in p53-and BRCA1-deficient mice. Cell Growth Differ. 10, 1-10 (1999).
37. Tseng, S.L. et al. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Genes Chromosomes Cancer 20, 377-382 (1997).
38. Yang, X., Li, C., Xu, X. & Deng, C. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad. Sci. USA 95, 3667-3672 (1998).
39. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. & Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921 (1996).
40. Deng, C.X. et al. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8, 3045-3057 (1994).
41. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. & Rajewsky, K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106 (1994).
42. Robinson, G.W. & Hennighausen, L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124, 2701-2708 (1997).
43. Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA 93, 5860-5865 (1996).
44. Johnson, P., Gray, D., Mowat, M. & Benchimol, S. Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol. Cell. Biol. 11, 1-11 (1991).